id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-E-0315-0010,FDA,FDA-2008-E-0315,U.S. Patent and Trademark Office to University of Strathclyde (K&L Gates) - Letter,Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T15:44:35Z,,0,0,09000064812bdde2
FDA-2008-E-0315-0009,FDA,FDA-2008-E-0315,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-04-24T04:00:00Z,2012,4,2012-04-24T04:00:00Z,,2012-04-24T12:08:57Z,,0,0,0900006480ff6b06
FDA-2008-E-0315-0008,FDA,FDA-2008-E-0315,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-03-15T04:00:00Z,2012,3,2012-03-15T04:00:00Z,,2024-03-15T10:34:06Z,,0,0,0900006480fd807f
FDA-2008-E-0315-0007,FDA,FDA-2008-E-0315,Determination of Regulatory Review Period for Purposes of Patent Extension: Fusilev (Levoleucovorin),Notice,General Notice,2011-06-23T04:00:00Z,2011,6,2011-06-23T04:00:00Z,2011-08-23T03:59:59Z,2011-06-23T13:49:49Z,2011-15689,0,0,0900006480e9c061
FDA-2008-E-0315-0006,FDA,FDA-2008-E-0315,FDA\CDER to United States Patent and Trademark Office - Letter,Other,LET-Letter,2011-06-03T04:00:00Z,2011,6,2011-06-03T04:00:00Z,,2011-06-03T14:23:01Z,,0,0,0900006480e3a8a9
FDA-2008-E-0315-0005,FDA,FDA-2008-E-0315,FDA\CDER to United States Patent and Trademark Office - Letter,Other,,2011-06-03T00:00:00Z,2011,6,,,2011-06-03T14:16:04Z,,0,1,0900006480e3611d
FDA-2008-E-0315-0003,FDA,FDA-2008-E-0315,USPTO to FDA/CDER - Letter,Other,LET-Letter,2010-12-22T05:00:00Z,2010,12,2010-12-22T05:00:00Z,,2010-12-22T15:54:05Z,,0,0,0900006480bbd24a
FDA-2008-E-0315-0004,FDA,FDA-2008-E-0315,US Patent & Trademark Office - Transmittal Form,Other,LET-Letter,2010-12-20T05:00:00Z,2010,12,,,2013-07-27T23:40:14Z,,0,0,0900006480bbd27d
FDA-2008-E-0315-0002,FDA,FDA-2008-E-0315,USPTO to FDA/Center for Drug Evaluation and Research - Letter,Other,LET-Letter,2008-07-11T04:00:00Z,2008,7,2008-07-11T04:00:00Z,,2008-07-11T23:24:23Z,,0,0,09000064805fb2e8
FDA-2008-E-0315-0001,FDA,FDA-2008-E-0315,University of Strathclyde - Patent Term Extension Application,Other,APP-Application,2008-07-11T04:00:00Z,2008,7,2008-07-11T04:00:00Z,,2013-08-11T02:53:54Z,,0,0,09000064805fb27f